3 March 2021
Grafenia plc
("Grafenia", the "Group" or "Company")
Block admission six monthly return & cancellation of block admission
Grafenia (AIM: GRA) makes the notification below pursuant to Schedule Six of the AIM Rules for Companies regarding its block admission in respect of the Company's 2017 SAYE Scheme. This block admission will be cancelled with an effective date of 4 March 2021.
The Company's issued share capital as at the date of this announcement comprises 114,490,828 ordinary shares of 1 pence each with one voting right per share ("Ordinary Shares"). The Company does not hold any shares in treasury and therefore the total number of Ordinary Shares with voting rights in the Company is 114,490,828.
The above figure of 114,490,828 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
| Name of company: | Grafenia plc | |||
| Name of scheme: | Company's 2017 SAYE Scheme | |||
| Period of return: | From: | 02/09/2020 | To: | 02/03/2021 |
| Number of securities not issued under the scheme at the beginning of the period: | 3,026,306 Ordinary Shares | |||
| Number of securities issued under the scheme during the period: | none | |||
| Balance under the scheme of securities not yet issued at the end of period: | 2,979,856 Ordinary Shares | |||
| Number of securities originally admitted and the date of admission: | 3,026,306 Ordinary Shares 2 March 2020 | |||
For further information:
| Grafenia plc |
|
|
| |
| Peter Gunning (Chief Executive Officer) | 07973 191 632 | |||
|
|
| |||
| Allenby Capital Limited (Nominated Adviser and broker) |
| |||
| David Hart / Liz Kirchner | 0203 328 5656 | |||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
